Marex Group plc
Position in CRL — Charles River Laboratories International, Inc.
CIK 1997464
London, X0
Position in CRL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$578,540
+$342,388 QoQ
Shares Held
2,551
+86.3% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#288
of 564 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Marex Group plc holds $5,474,048 across 11 Diagnostics & Research names. CRL ranks #3 (10.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
2,266 | $1,136,081 | |
| 2 | DHR |
Danaher Corp /De/
|
4,403 | $838,682 | |
| 3 | CRL |
Charles River Laboratories International, Inc.
This page
|
2,551 | $578,540 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
1,007 | $530,124 | |
| 5 | NTRA |
Natera, Inc.
|
1,705 | $462,822 | |
| 6 | LH |
Labcorp Holdings Inc.
|
1,600 | $448,000 | |
| 7 | DGX |
Quest Diagnostics Inc
|
1,801 | $381,721 | |
| 8 | A |
Agilent Technologies, Inc.
|
2,752 | $365,548 |
All Filings in CRL
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $578,540 | 2,551 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $236,152 | 1,369 | Shares | Defined | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||